Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Circ Heart Fail. 2023 Sep 13;16(11):e010618. doi: 10.1161/CIRCHEARTFAILURE.123.010618

Table 3.

Association of cardiometabolic traits and obesity-related biomarkers with HFpEF

MV-adjusted model
OR (95% CI) p-value
Cardiometabolic Traits
Diabetes 1.89 (1.04–3.41) 0.04
Obesity 1.96 (1.30−2.96) 0.001
BMI 1.06 (1.03−1.10) <0.001
Obesity-Related Biomarkers
CRP 1.25 (1.03−1.52) 0.03
IL-6 1.15 (0.95−1.40) 0.16
HOMA-IR 1.26 (0.98−1.62) 0.07
Adiponectin 0.97 (0.79−1.19) 0.77
Leptin 1.36 (1.09−1.70) 0.007
Resistin 0.92 (0.75−1.11) 0.37
NT-pro BNP 1.54 (1.21−1.94) <0.001

Odds ratio represents point estimate and 95% confidence interval of HFpEF per 1 unit change in BMI and per 1-SD unit change in log-transformed biomarkers in multivariable regression models adjusted for age, sex, hypertension, diabetes, current smoking, and previous myocardial infarction. Analyses for HOMA-IR excludes individuals with diabetes. Abbreviations: MV = multivariable; OR = odds ratio; CI = confidence interval; CRP = high-sensitivity C-reactive protein; IL-6 = interleukin-6; HOMA-IR= homeostatic model assessment of insulin resistance; NT-pro BNP = N-terminal pro-B-type natriuretic peptide.